Literature DB >> 9569101

Trypanosoma cruzi: IgG1 and IgG2b are the main immunoglobulins produced by vaccinated mice.

A S Pyrrho1, J L Moraes, L M Peçanha, C R Gattass.   

Abstract

Mice vaccinated with CL-14, a non-infective and non-pathogenic clone isolated from Trypanosoma cruzi CL strain, become protected against lethal challenge by infective trypomastigotes. It has been shown that animals infected with T. cruzi show polyclonal activation of B lymphocytes with an early production of several non-specific immunoglobulins. Vaccinated mice, however, have an early production of antigen-specific IgG1 and IgG2b. Considering the lack of infectivity of CL-14, our data strongly suggest a role for IgG1 and IgG2b in protection to T. cruzi.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9569101     DOI: 10.1007/s004360050406

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  5 in total

1.  Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies.

Authors:  Daniela A Bermejo; María C Amezcua Vesely; Mahmood Khan; Eva V Acosta Rodríguez; Carolina L Montes; Maria C Merino; Kai Michael Toellner; Elodie Mohr; Dale Taylor; Adam F Cunningham; Adriana Gruppi
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

2.  Modulation of cardiocyte functional activity by antibodies against trypanosoma cruzi ribosomal P2 protein C terminus.

Authors:  P Sepulveda; P Liegeard; G Wallukat; M J Levin; M Hontebeyrie
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.

Authors:  Rômulo Dias Novaes; Marcus Vinicius Pessoa Sartini; João Paulo Ferreira Rodrigues; Reggiani Vilela Gonçalves; Eliziária Cardoso Santos; Raquel Lopes Martins Souza; Ivo Santana Caldas
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

4.  Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.

Authors:  Vandanajay Bhatia; Nisha Jain Garg
Journal:  Clin Vaccine Immunol       Date:  2008-06-11

5.  IgG Subclass Analysis in Patients with Chagas Disease 4 Years After Benznidazole Treatment.

Authors:  Maurício Llaguno; Marcos Vinícius da Silva; Fernanda Rodrigues Helmo; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Acta Parasitol       Date:  2021-06-11       Impact factor: 1.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.